Laura A. Williams - Jan 5, 2023 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role: Chief Medical Officer
Signature: /s/ Elizabeth Grammer, Attorney-in-Fact for Laura A. Williams
Stock symbol: ARDX
Transactions as of: Jan 5, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/6/2023, 03:23 PM
Previous filing: Nov 23, 2022
Next filing: Feb 24, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARDX	Common Stock	Award	$0	+78K	+31.94%	$0.00	322K	Jan 5, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARDX	Stock Option (Right to Buy)	Award	$0	+351K		$0.00	351K	Jan 5, 2023	Common Stock	351K	$2.73	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.
F2	The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.